Lorenzo Pierangelo Treccani
Papers
2
Total Citations
25
H-Index
2
About
Lorenzo Pierangelo Treccani is a pioneering urologic surgeon whose research is reshaping the surgical management of prostate cancer. His primary focus lies in the comparative effectiveness of robotic surgical systems, specifically evaluating next-generation platforms like the Hugo™ RAS against the established da Vinci® Xi. Treccani’s landmark work, the COMPAR-P prospective trial, provides critical, real-world evidence on postoperative recovery, oncological outcomes, and patient-reported quality of life following robot-assisted radical prostatectomy (RARP). This highly cited study (23 citations) is a cornerstone for surgeons adopting new robotic technologies. Beyond comparative robotics, Treccani has advanced risk stratification by validating the 2012 Briganti nomogram as a predictor of disease progression in high-risk prostate cancer patients, helping to refine surgical decision-making. His work directly addresses the pressing clinical need to optimize surgical precision while minimizing functional impact. By combining rigorous prospective trial methodology with a focus on patient-centered outcomes, Treccani is not just evaluating new tools; he is defining the evidence-based standards for the next generation of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2